Author

Jessica Hailstone

Observed names: Hailstone, Jessica, J Hailstone, J. Hailstone

Observed institutions: Leicester Royal Infirmary, Royal Shrewsbury Hospital, The Christie NHS Foundation Trust, Shrewsbury and Telford Hospital NHS Trust

OpenAlex ID: A5005320805

Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis

2022 · Obbina Abani, Ali Abbas, et al. · The Lancet · 324

GWAS and meta-analysis identifies 49 genetic variants underlying critical COVID-19

2023 · Erola Pairo-Castineira, Konrad Rawlik, et al. · Nature · 224

Safety, immunogenicity, and reactogenicity of BNT162b2 and mRNA-1273 COVID-19 vaccines given as fourth-dose boosters following two doses of ChAdOx1 nCoV-19 or BNT162b2 and a third dose of BNT162b2 (COV-BOOST): a multicentre, blinded, phase 2, randomised trial

2022 · Alasdair P S Munro, Shuo Feng, et al. · The Lancet Infectious Diseases · 175

Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial

2023 · Obbina Abani, Ali Abbas, et al. · The Lancet · 129

A second update on mapping the human genetic architecture of COVID-19

2023 · The COVID-19 Host Genetics Initiative, Leadership, et al. · Nature · 118

Dexmedetomidine- or Clonidine-Based Sedation Compared With Propofol in Critically Ill Patients

2025 · Timothy S. Walsh, Timothy S. Walsh, et al. · JAMA · 54

Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

2023 · O Abani, A Abbas, et al. · The Lancet Diabetes & Endocrinology · 41

Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial

2024 · Saul N Faust, Richard Haynes, et al. · The Lancet Child & Adolescent Health · 39

Molnupiravir or nirmatrelvir–ritonavir plus usual care versus usual care alone in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

2025 · O Abani, A Abbas, et al. · The Lancet Infectious Diseases · 12

Author Correction: GWAS and meta-analysis identifies 49 genetic variants underlying critical COVID-19

2023 · Erola Pairo-Castineira, Konrad Rawlik, et al. · Nature · 9

Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial

2025 · O. Abani, A. Abbas, et al. · EClinicalMedicine · 5

Cost-Effectiveness of α2 Agonists for Intravenous Sedation in Patients With Critical Illness

2025 · Stephen Morris, Nazir I. Lone, et al. · JAMA Network Open · 4

Sotrovimab versus usual care in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

2025 · O Abani, A Abbas, et al. · The Lancet Infectious Diseases

Works count: 14

Citation count: 1,131

H-index: 9

I10-index: 9